Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.

Profile Publications(13)
XB-PERS-2109

Publications By Judith L. Campbell

Results 1 - 13 of 13 results

Page(s): 1

Xenopus DNA2 is a helicase/nuclease that is found in complexes with replication proteins And-1/Ctf4 and Mcm10 and DSB response proteins Nbs1 and ATM.
Wawrousek KE, Fortini BK, Polaczek P, Chen L, Liu Q, Dunphy WG, Campbell JL.
Cell Cycle. March 15, 2010; 9 (6): 1156-66.

Identification of a functionally important negatively charged residue within the second catalytic site of the SUR1 nucleotide-binding domains.
Campbell JD, Proks P, Lippiat JD, Sansom MS, Ashcroft FM.
Diabetes. December 1, 2004; 53 Suppl 3 S123-7.

Identification of the Xenopus laevis homolog of Saccharomyces cerevisiae DNA2 and its role in DNA replication.
Liu Q, Choe W, Campbell JL.
J Biol Chem. January 21, 2000; 275 (3): 1615-24.

ABT-594 [(R)-5-(2-azetidinylmethoxy)-2-chloropyridine]: a novel, orally effective analgesic acting via neuronal nicotinic acetylcholine receptors: I. In vitro characterization.
Donnelly-Roberts DL, Puttfarcken PS, Kuntzweiler TA, Briggs CA, Anderson DJ, Campbell JE, Piattoni-Kaplan M, McKenna DG, Wasicak JT, Holladay MW, Williams M, Arneric SP.
J Pharmacol Exp Ther. May 1, 1998; 285 (2): 777-86.

Identification and initial structure-activity relationships of (R)-5-(2-azetidinylmethoxy)-2-chloropyridine (ABT-594), a potent, orally active, non-opiate analgesic agent acting via neuronal nicotinic acetylcholine receptors.
Holladay MW, Wasicak JT, Lin NH, He Y, Ryther KB, Bannon AW, Buckley MJ, Kim DJ, Decker MW, Anderson DJ, Campbell JE, Kuntzweiler TA, Donnelly-Roberts DL, Piattoni-Kaplan M, Briggs CA, Williams M, Arneric SP.
J Med Chem. February 12, 1998; 41 (4): 407-12.

ABT-089 [2-methyl-3-(2-(S)-pyrrolidinylmethoxy)pyridine]: I. A potent and selective cholinergic channel modulator with neuroprotective properties.
Sullivan JP, Donnelly-Roberts D, Briggs CA, Anderson DJ, Gopalakrishnan M, Xue IC, Piattoni-Kaplan M, Molinari E, Campbell JE, McKenna DG, Gunn DE, Lin NH, Ryther KB, He Y, Holladay MW, Wonnacott S, Williams M, Arneric SP.
J Pharmacol Exp Ther. October 1, 1997; 283 (1): 235-46.

A-85380 [3-(2(S)-azetidinylmethoxy) pyridine]: in vitro pharmacological properties of a novel, high affinity alpha 4 beta 2 nicotinic acetylcholine receptor ligand.
Sullivan JP, Donnelly-Roberts D, Briggs CA, Anderson DJ, Gopalakrishnan M, Piattoni-Kaplan M, Campbell JE, McKenna DG, Molinari E, Hettinger AM, Garvey DS, Wasicak JT, Holladay MW, Williams M, Arneric SP.
Neuropharmacology. June 1, 1996; 35 (6): 725-34.

Stable expression and pharmacological properties of the human alpha 7 nicotinic acetylcholine receptor.
Gopalakrishnan M, Buisson B, Touma E, Giordano T, Campbell JE, Hu IC, Donnelly-Roberts D, Arneric SP, Bertrand D, Sullivan JP.
Eur J Pharmacol. August 15, 1995; 290 (3): 237-46.

Variations in differentiation in the regenerating lens of Xenopus laevis.
Campbell JC, Truman DE.
Exp Eye Res. July 1, 1977; 25 (1): 99-100.

The subunit structure of chick lens crystallins and its relationship to their antigenic properties.
Truman DE, Clayton RM, Burns AT, Campbell JC.
Indian J Ophthalmol. June 1, 1972; 20 (2): 55-62.

Antigens of the lens of Xenopus laevis.
Campbell JC, Clayton RM, Truman DE.
Exp Eye Res. January 1, 1968; 7 (1): 4-10.

The in vitro development of lens from cornea of larval Xenopus laevis.
Campbell JC, Jones KW.
Dev Biol. January 1, 1968; 17 (1): 1-15.

AN IMMUNO-FLUORESCENT STUDY OF LENS REGENERATION IN LARVAL XENOPUS LAEVIS.
CAMPBELL JC.
J Embryol Exp Morphol. February 1, 1965; 13 171-9.

Page(s): 1

My Xenbase: [ Log-in / Register ]
version: [4.7.1]

Major funding for Xenbase is provided by the National Institute of Child Health and Human Development, grant P41 HD064556